Home > Initiatives > Stem Cell Action Coalition
The Stem Cell Action Coalition serves as an engine uniting the pro-cures community. We demand that both our elected and appointed officials in all branches and levels of government, federal and state, establish embryonic stem cell research as a national public health priority. So focused, these officials need to enact and uphold laws that protect funding for scientifically meritorious and ethically responsible research that will foster the emergence of cures sooner, rather than later.
Embryonic stem cell research has been called the most promising medical discovery of our time, and it remains the “gold standard” for stem cell scientists.
Cell lines derived from embryonic stem cells (ESCs) serve as a means to understand developmental biology, a field second to none in importance for dissecting the root causes of a broad spectrum of diseases. As such, these cell lines provide tools for drug discovery and development of cell therapies for curing a host of disabling and often deadly medical conditions, and for which current and continuing needs are unmet. These include, among others, multiple sclerosis, cancer, diabetes, heart disease, spinal cord injury, stroke, blindness, AIDS, Parkinson’s disease, Alzheimer’s, birth defects and many more.
After years of funding restrictions, research with human embryonic stem cells is now under a legal cloud that may cut off research funding permanently, thereby threatening the emergence of cures for otherwise incurable conditions affecting the lives and health of over 100 million Americans.
The 2010 election has empowered the foes of embryonic stem cell research. Their agenda is aided by well-funded social-conservative organizations that poured millions of dollars into bioethics think tanks dedicated to crippling the quest for cures.
Blocking federal funding of human embryonic stem cell research in the US will be devastating to patients, researchers, industry and the economy of the United States of America and the field of biological research.
Moreover, unless the pro-cures community mobilizes and takes action, more restrictive legislation at both the federal and state levels may be adopted. Research foes plan an aggressive agenda to block embryonic stem cell research legislatively at both the federal and state level and in the courts.
-
Stem cell group, Genetics Policy Institute, plans summit in WPB next year
Dec 25, 2011 -
UM’s Stem Cell and Diabetes Research Institutes Co-Sponsor World Stem Cell Summit
Dec 15, 2011 - Watch the 2011 Summit Webcast
Oct 03, 2011
8th World Stem Cell Summit Announcement
On December 15, 2011, Genetics Policy Institute (GPI) Founder and Executive Director Bernard Siegel joined South Florida leaders at the Palm Beach County Convention Center to announce the selection of West Palm Beach, Florida as host of the 8th World Stem Cell Summit, Dec 3-5, 2012.
- International Translational Regenerative Medicine Center Seminar
State of the Industry Briefing
02.14.2012
Arnold Beckman Center
City of Hope Duarte, California - SPI 2012:
Science, partnering and Investment Forum
Gateway for the Global Life Sciences
05.12.2012
Palm Beach County Convention Center
West Palm Beach, Florida - 18th Annual Meeting - International Society for Cellular Therapy (ISCT)
06.08.2012
Sheraton Seattle Hotel
Seattle, Washington
